These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37683612)

  • 21. The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice.
    Liu X; Yuan H; Niu Y; Niu W; Fu L
    Biochim Biophys Acta; 2012 Nov; 1822(11):1716-26. PubMed ID: 22846606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1.
    Fang Y; Park IH; Wu AL; Du G; Huang P; Frohman MA; Walker SJ; Brown HA; Chen J
    Curr Biol; 2003 Dec; 13(23):2037-44. PubMed ID: 14653992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
    Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
    Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
    Fingar DC; Richardson CJ; Tee AR; Cheatham L; Tsou C; Blenis J
    Mol Cell Biol; 2004 Jan; 24(1):200-16. PubMed ID: 14673156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperglycemia-induced Bcl-2/Bax-mediated apoptosis of Schwann cells via mTORC1/S6K1 inhibition in diabetic peripheral neuropathy.
    Zhu L; Hao J; Cheng M; Zhang C; Huo C; Liu Y; Du W; Zhang X
    Exp Cell Res; 2018 Jun; 367(2):186-195. PubMed ID: 29621478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.
    Rosner M; Hengstschläger M
    Oncogene; 2011 Nov; 30(44):4509-22. PubMed ID: 21602892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.
    Gao S; Duan C; Gao G; Wang X; Yang H
    Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc stimulates glucose consumption by modulating the insulin signaling pathway in L6 myotubes: essential roles of Akt-GLUT4, GSK3β and mTOR-S6K1.
    Wu Y; Lu H; Yang H; Li C; Sang Q; Liu X; Liu Y; Wang Y; Sun Z
    J Nutr Biochem; 2016 Aug; 34():126-35. PubMed ID: 27295130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.
    Wang H; Brown J; Gu Z; Garcia CA; Liang R; Alard P; Beurel E; Jope RS; Greenway T; Martin M
    J Immunol; 2011 May; 186(9):5217-26. PubMed ID: 21422248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fisetin regulates obesity by targeting mTORC1 signaling.
    Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
    J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17β-estradiol activates mTOR in chondrocytes by AKT-dependent and AKT-independent signaling pathways.
    Tao Y; Sun H; Sun H; Qiu X; Xu C; Shi C; Du J
    Int J Clin Exp Pathol; 2015; 8(12):15911-8. PubMed ID: 26884863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin induces expression of FGF-2 via activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility in vascular smooth muscle cells.
    Cao H; Dronadula N; Rao GN
    Am J Physiol Cell Physiol; 2006 Jan; 290(1):C172-82. PubMed ID: 16148030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
    Byfield MP; Murray JT; Backer JM
    J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
    Lee SJ; Yang EK; Kim SG
    Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.
    Hou X; Arvisais EW; Davis JS
    Endocrinology; 2010 Jun; 151(6):2846-57. PubMed ID: 20351317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Akt regulates skeletal development through GSK3, mTOR, and FoxOs.
    Rokutanda S; Fujita T; Kanatani N; Yoshida CA; Komori H; Liu W; Mizuno A; Komori T
    Dev Biol; 2009 Apr; 328(1):78-93. PubMed ID: 19389373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD.
    Saito Y; Tanaka Y; Aita Y; Ishii KA; Ikeda T; Isobe K; Kawakami Y; Shimano H; Hara H; Takekoshi K
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E615-25. PubMed ID: 21878661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Icariside II promotes the osteogenic differentiation of canine bone marrow mesenchymal stem cells via the PI3K/AKT/mTOR/S6K1 signaling pathways.
    Luo G; Xu B; Huang Y
    Am J Transl Res; 2017; 9(5):2077-2087. PubMed ID: 28559962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy.
    Sathe A; Chalaud G; Oppolzer I; Wong KY; von Busch M; Schmid SC; Tong Z; Retz M; Gschwend JE; Schulz WA; Nawroth R
    PLoS One; 2018; 13(1):e0190854. PubMed ID: 29357370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.